KN

K Nominees

Description

K Nominees was added in 2009.

Investor Profile

K Nominees has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown rounds (top funding stages).
  • Majority of deals are located in United Kingdom.
  • Strong thematic focus on Biotechnology, Genetics, Health Care.

Stage Focus

  • Series Unknown (100%)

Country Focus

  • United Kingdom (100%)

Industry Focus

  • Biotechnology
  • Genetics
  • Health Care
  • Medical
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does K Nominees frequently co-invest with?

Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1
Fraser
Europe, England, United Kingdom, London
Co-Investments: 1
Merifin Capital
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 2
Advent Venture Partners
Europe, England, United Kingdom, London
Co-Investments: 1
Astellas Venture Management
North America, California, United States, Menlo Park
Co-Investments: 2
Sunstone Life Science Ventures
Europe, Hovedstaden, Denmark, Copenhagen
Co-Investments: 1

What are some of recent deals done by K Nominees?

F2G

Manchester, Manchester, United Kingdom

F2G discovers and develops novel drugs for the treatment of life-threatening fungal diseases.

BiotechnologyGeneticsHealth CareMedicalPharmaceutical
Series UnknownSep 5, 2012
Amount Raised: $30,000,000
F2G

Manchester, Manchester, United Kingdom

F2G discovers and develops novel drugs for the treatment of life-threatening fungal diseases.

BiotechnologyGeneticsHealth CareMedicalPharmaceutical
Series UnknownAug 18, 2008
Amount Raised: $11,753,687